Literature DB >> 2189821

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.

I R Wanless1.   

Abstract

Nodular regenerative hyperplasia is defined by hepatocellular nodules distributed throughout the liver in the absence of fibrous septa between the nodules. Most reports have been single cases so that the prevalence and clinical significance of nodular regenerative hyperplasia is uncertain. In this study, the hepatic histology of 2,500 consecutive autopsies was reviewed. A spectrum of nodular transformation was found with nodular regenerative hyperplasia present in 2.6% of autopsy livers and qualitatively similar but lesser degrees of nodular transformation in a further 10.2%. Nodular transformation was also seen in 47% of livers with cirrhosis and 69% with incomplete cirrhosis. Obliteration of many small portal veins was seen in all cases with nodular regenerative hyperplasia, but only 4.7% of these had evidence of portal hypertension. The prevalence of various clinical states was compared in nodular regenerative hyperplasia and in controls. The results confirm, extend and quantify the spectrum of associated diseases. Nodular regenerative hyperplasia occurs in 5.6% of individuals over age 80 and with increased frequency in patients with systemic arteritis, polymyalgia rheumatica, massive tumor infiltration and mineral oil deposition. Nodular regenerative hyperplasia appears to be the hepatic analogue of arterial and arteriolar nephrosclerosis. A new classification of nodular transformation is proposed that encompasses the spectrum of lesions described here and the previously defined entities of focal nodular hyperplasia, partial nodular transformation and "cirrhosis telangiectasia hepatis." The major conclusion is that nodular regenerative hyperplasia is a secondary and nonspecific tissue adaptation to heterogeneous distribution of blood flow and does not represent a specific entity.

Entities:  

Mesh:

Year:  1990        PMID: 2189821     DOI: 10.1002/hep.1840110512

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  104 in total

Review 1.  Thorotrast associated nodular regenerative hyperplasia of the liver.

Authors:  T W Beer; N J Carr; P J Buxton
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

2.  Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.

Authors:  Teijiro Hirashita; Masayuki Ohta; Seiichiro Kai; Takashi Masuda; Hidetoshi Eguchi; Yukio Iwashita; Tadashi Ogawa; Seigo Kitano
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

3.  Nodular regenerative hyperplasia of the liver associated with didanosine persists for years even after its interruption.

Authors:  Daniel Hofmaenner; Helen Kovari; Achim Weber; Dominik Weishaupt; Roberto F Speck
Journal:  BMJ Case Rep       Date:  2011-05-03

4.  Oestrogen hormone receptors in focal nodular hyperplasia.

Authors:  Manju D Chandrasegaram; Ali Shah; John W Chen; Andrew Ruszkiewicz; David S Astill; Georgina England; Ravish S Raju; Eu Ling Neo; Paul M Dolan; Chuan Ping Tan; Mark Brooke-Smith; Tom Wilson; Robert T A Padbury; Christopher S Worthley
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

Review 5.  [Nodular lesions of liver parenchyma caused by pathological vascularisation/perfusion].

Authors:  H-P Fischer; H Zhou
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

6.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Authors:  G Vernier-Massouille; J Cosnes; M Lemann; P Marteau; W Reinisch; D Laharie; G Cadiot; Y Bouhnik; M De Vos; A Boureille; B Duclos; P Seksik; J-Y Mary; J-F Colombel
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

Review 7.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 8.  Vascular liver diseases.

Authors:  Laurie D DeLeve
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  Nodular regenerative hyperplasia in common variable immunodeficiency.

Authors:  Ivan J Fuss; Julia Friend; Zhiqiong Yang; Jian Ping He; Lubna Hooda; James Boyer; Liqiang Xi; Mark Raffeld; David E Kleiner; Theo Heller; Warren Strober
Journal:  J Clin Immunol       Date:  2013-02-19       Impact factor: 8.317

Review 10.  Human immunodeficiency virus and nodular regenerative hyperplasia of liver: A systematic review.

Authors:  Archita Sood; Mariana Castrejón; Sammy Saab
Journal:  World J Hepatol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.